The Allstate Co. (NYSE:ALL – Get Free Report) announced a quarterly dividend on Thursday, November 14th,RTT News reports. Investors of record on Friday, November 29th will be paid a dividend of 0.92 per share by the insurance provider on Thursday, January 2nd. This represents a $3.68 annualized dividend and a yield of 1.88%.
Allstate has raised its dividend payment by an average of 18.1% per year over the last three years and has increased its dividend annually for the last 14 consecutive years. Allstate has a payout ratio of 20.1% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect Allstate to earn $19.07 per share next year, which means the company should continue to be able to cover its $3.68 annual dividend with an expected future payout ratio of 19.3%.
Allstate Stock Performance
ALL traded down $1.59 during mid-day trading on Thursday, reaching $195.71. 193,185 shares of the company traded hands, compared to its average volume of 1,539,599. The company’s fifty day moving average price is $189.58 and its 200-day moving average price is $176.40. The stock has a market capitalization of $51.82 billion, a P/E ratio of 12.78, a P/E/G ratio of 1.77 and a beta of 0.48. The company has a quick ratio of 0.40, a current ratio of 0.40 and a debt-to-equity ratio of 0.43. Allstate has a 52-week low of $130.77 and a 52-week high of $201.00.
Insiders Place Their Bets
In related news, insider John E. Dugenske sold 36,367 shares of the firm’s stock in a transaction on Friday, September 20th. The shares were sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the completion of the transaction, the insider now directly owns 27,364 shares of the company’s stock, valued at approximately $5,236,922.32. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In other news, CEO Thomas J. Wilson sold 90,000 shares of the company’s stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $179.34, for a total transaction of $16,140,600.00. Following the sale, the chief executive officer now directly owns 88,552 shares of the company’s stock, valued at $15,880,915.68. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider John E. Dugenske sold 36,367 shares of the firm’s stock in a transaction on Friday, September 20th. The shares were sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the completion of the transaction, the insider now directly owns 27,364 shares of the company’s stock, valued at approximately $5,236,922.32. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 192,530 shares of company stock worth $34,967,665 in the last three months. 1.80% of the stock is owned by company insiders.
Analyst Upgrades and Downgrades
Several equities analysts have recently weighed in on the stock. StockNews.com cut shares of Allstate from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, August 21st. Evercore ISI increased their price target on shares of Allstate from $191.00 to $195.00 and gave the stock an “in-line” rating in a research report on Wednesday, October 9th. UBS Group boosted their price objective on shares of Allstate from $216.00 to $225.00 and gave the company a “buy” rating in a research report on Monday, November 4th. Keefe, Bruyette & Woods raised their target price on Allstate from $222.00 to $225.00 and gave the stock an “outperform” rating in a report on Wednesday, November 6th. Finally, Raymond James lifted their target price on Allstate from $205.00 to $220.00 and gave the company a “strong-buy” rating in a research report on Friday, October 4th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, Allstate has an average rating of “Moderate Buy” and a consensus target price of $212.56.
Get Our Latest Research Report on Allstate
About Allstate
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Further Reading
- Five stocks we like better than Allstate
- How to Calculate Options Profits
- 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick
- What to Know About Investing in Penny Stocks
- Mouse Rising: The Iger Investment Pays Off for Disney Investors
- Profitably Trade Stocks at 52-Week Highs
- Can CAVA Stock Be the Next Chipotle? Earnings Can Help
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.